Assistant Professor, Immunoengineering

Assistant Professor, Immunoengineering

The Schulich School of Engineering, in partnership with the Riddell Centre for Cancer Immunotherapy/Charbonneau Cancer Institute, Alberta Children’s Hospital Research Institute (ACHRI), and the Snyder Institute at the University of Calgary, invites national and international applications for a full‑time, tenure‑track position at the rank of Assistant Professor, with an anticipated start date of May 1, 2026.

Successful candidates will be appointed to the Department of Biomedical Engineering and will be expected to actively contribute to research, student and postdoctoral supervision, undergraduate and graduate teaching, curriculum development, teaching and service contributions to the department, faculty and university. The role offers opportunities to grow into leadership positions within the department, school and university.

• Develop and lead an internationally recognized research program in immunoengineering.
• Secure competitive external funding and recruit high‑quality trainees.
• Teach undergraduate and graduate courses aligned with expertise and in some cases design new courses.
• Provide service to the department, faculty and university, including committee participation.
• Promote equitable, diverse, inclusive and accessible employment practices.
• Contribute to the University’s Forward‑Thinking research agenda and industry collaboration.

• Doctoral degree (or equivalent) in engineering, life sciences or a related discipline.
• Bachelor’s degree in engineering or equivalent.
• Emerging scholarly profile with an original, innovative research program expected to gain international recognition within 5-10 years.
• Proven potential for collaboration with existing researchers and research groups on campus.
• Eligible for registration as a professional engineer with the Association of Professional Engineers and Geoscientists of Alberta (APEGA).

Immune‑related engineering (immunoengineering) across a broad range of topics including, but not limited to:

• Biomimetic materials, immuno‑oncology, molecular engineering, synthetic biology, cell‑based therapies, systems immunology, computational immunoengineering, biomanufacturing, regenerative immunology.
• Advanced in‑vitro model systems such as organ‑on‑chip and microphysiological platforms for studying immune‑tissue interactions.
• Translational applications spanning vaccine design, immunomodulatory biomaterials and other diagnostic and therapeutic innovations.

Interested candidates are encouraged to submit an application online via the “Apply Now” link. The application process allows for only four attachments. The recommended attachments are:

• Cover letter, curriculum vitae, and name/contact information of three referees.
• Statement of research interests, accomplishments and vision (maximum 2 pages), including potential collaborations and funding strategy.
• Statement of teaching philosophy (maximum 2 pages) highlighting experience and prospective courses.
• Statement on equity, diversity and inclusion (maximum 2 pages).

Applications are accepted until April 1, 2026
.

Dr. Michael Kallos
Head, Department of Biomedical Engineering
Email:

The University of Calgary complies with applicable anti‑discrimination legislation and encourages applications from women, Indigenous peoples, persons with disabilities, visible/racialised minorities and diverse sexual orientation and gender identities. Applicants with disabilities are offered accommodation at any stage of the recruitment process.

Canadian citizens and permanent residents will be given priority. Applicants should answer the following question when applying:
Are you a Canadian citizen or a permanent resident of Canada? (Yes/No)